Corcept Therapeutics Incorporated · NASDAQ:CORT
Mokari Atabak received 276 Corcept Therapeutics Incorporated shares as an award (Form 4)
Traded Sep 1 to Sep 2, 2026 · Filed Sep 3, 2026
From Sep 1 to Sep 2, 2026, Mokari Atabak (Chief Financial Officer) received 276 Corcept Therapeutics Incorporated shares as an award at US$113.38 for US$15,646, leaving 16,304 shares. Filed Sep 3, 2026 (Form 4).
- Awarded
- 276 shares
- Price
- US$113.38
- Value
- US$15,646
- Holding after
- 16,304 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | Award | 138 | US$113.38 | 16,268 | Direct |
| Sep 1, 2026 | Common Stock | Award | 138 | 16,406 | Direct | |
| Sep 2, 2026 | Common Stock | Shares withheld for tax | 102 | US$113.38 | 16,304 | Direct |
Source
Related
- Corcept Therapeutics Incorporated
- Mokari Atabak
- Corcept Therapeutics Incorporated shareholders
- Form 4 · Mokari Atabak · Aug 3, 2026
- Form 4 · Mokari Atabak · Jul 17, 2026
- Form 4 · Mokari Atabak · Jun 17, 2026
- Form 4 · Mokari Atabak · Jun 3, 2026
- Form 4 · Wilson James N · Oct 16, 2026
- Form 4 · Vieira Roberto Wandenkolk · Oct 5, 2026
- Form 4 · Maduck Sean · Oct 5, 2026
- Form 4 · Lyon Joseph Douglas · Oct 5, 2026
- Form 4 · Robb Gary Charles · Sep 28, 2026